Menu
Search
|

Menu

Close
X

Soleno Therapeutics Inc SLNO.OQ (NASDAQ Stock Exchange Capital Market)

2.55 USD
-0.08 (-3.04%)
As of Jul 23
Previous Close 2.63
Open 2.63
Volume 8,133
3m Avg Volume 292,198
Today’s High 2.65
Today’s Low 2.55
52 Week High 5.06
52 Week Low 1.11
Shares Outstanding (mil) 9.58
Market Capitalization (mil) 23.39
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 2 analysts

KEY STATS

Revenue (mm, USD)
FY19
0
FY18
0
FY17
0
FY16
0
EPS (USD)
FY19
-0.221
FY18
-0.613
FY17
-0.276
FY16
-3.560
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.67
Price to Sales (TTM)
vs sector
37.92
7.92
Price to Book (MRQ)
vs sector
0.87
5.39
Price to Cash Flow (TTM)
vs sector
--
24.37
Total Debt to Equity (MRQ)
vs sector
0.00
14.56
LT Debt to Equity (MRQ)
vs sector
0.00
10.21
Return on Investment (TTM)
vs sector
-68.04
14.49
Return on Equity (TTM)
vs sector
-98.99
15.79

EXECUTIVE LEADERSHIP

Anish Bhatnagar
President, Chief Executive Officer, Interim Principal Financial and Accounting Officer, Director, Since 2017
Salary: $446,000.00
Bonus: $230,000.00
Jonathan Wolter
Principal Financial and Accounting Officer, Since 2018
Salary: --
Bonus: --
Anthony Wondka
Senior Vice President Research and Development, Since 2013
Salary: $270,000.00
Bonus: --
Ernest Mario
Chairman of the Board, Since 2014
Salary: --
Bonus: --
Gwen Melincoff
Director, Since 2019
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

1235 Radio Rd Ste 110
REDWOOD CITY   CA   94065-1217

Phone: +1650.2138444

Soleno Therapeutics, Inc., formerly Capnia, Inc., is a healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon monoxide (ETCO) Monitor, NeoPIP Infant Resuscitator and Accessories, and Serenz Nasal Relief. The Company has developed the CoSense End-Tidal Carbon Monoxide Monitor that measures ETCO for the detection of dangerous hemolysis rates. The Infant Solutions product line, including the NeoPIP Infant Resuscitator Unit and accessories, is designed for controlled and accurate resuscitation of neonates and infants in the clinical environment. Serenz Nasal Relief is a hand-held nasal irrigator that uses carbon dioxide (CO2) gas to wash the nasal passages.

SPONSORED STORIES